Clay Ritchey was named Chief Executive Officer of Definitive Healthcare Corp., succeeding Kevin Coop, effective September 8, 2026. As of November 10, 2026, Definitive Healthcare Corp. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 3, 2026 to September 2, 2026, naming 1 appointment and 1 departure (Form 8-K, September 2, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Definitive Healthcare Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Definitive Healthcare Corp. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-03 to 2026-09-02. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Definitive Healthcare Corp. files it.
Also on the record for Definitive Healthcare Corp.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 9, 2026 | Stake report, Schedule 13G/A, by THE GOLDMAN SACHS GROUP, INC. | 1% of the class | 5%+ stakes | Source |
| October 1, 2026 | Stake report, Schedule 13D/A, by Advent International, L.P. | 58.54% of the class | 5%+ stakes | Source |
| September 2, 2026 | Stake report, Schedule 13D, by Advent International, L.P. | 58.54% of the class | 5%+ stakes | Source |
| September 2, 2026 | Stake report, Schedule 13D, by Jason Ronald Krantz | 17.6% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G/A, by Advent International, L.P. | 59.82% of the class | 5%+ stakes | Source |
| February 9, 2026 | Stake report, Schedule 13G/A, by THE GOLDMAN SACHS GROUP, INC. | 5.7% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Definitive Healthcare Corp. now and the warning signs.
Free to see. No signup.
Keep reading
More on Definitive Healthcare Corp. and the records around it.
Definitive Healthcare Corp. elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Advent International, L.P. also filed stake reports on 5 other companies: Intuitive Machines, Inc. (Jan 2026), CCC INTELLIGENT SOLUTIONS HOLDINGS INC. (Nov 2025), First Watch Restaurant Group, Inc. (Nov 2025)
- THE GOLDMAN SACHS GROUP, INC. also filed stake reports on 173 other companies: AEON ACQUISITION I CORP. (Nov 2026), ALPEX ACQUISITION CORPORATION (Nov 2026), ARCHIMEDES TECH SPAC PARTNERS II CO. (Nov 2026)
Watch Definitive Healthcare Corp.
Get an email when Definitive Healthcare Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Definitive Healthcare Corp.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Definitive Healthcare Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Definitive Healthcare Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-02 | In | Chief Executive Officer | 2026-09-08 | 8-K, 2026-09-02 | |
| 2026-09-02 | Out | Chief Executive Officer | 2026-08-31 | 8-K, 2026-09-02 | |
| 2026-04-03 | Reported | not named in the filing | 8-K, 2026-04-03 |
Who leads Definitive Healthcare Corp., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Clay Ritchey, appointed, effective 2026-09-08 (filed 2026-09-02).
New leaders reset buying decisions — get the Full Report on Definitive Healthcare Corp.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Definitive Healthcare Corp., with the record behind each one.
Find candidates like Chief Executive Officer at Definitive Healthcare Corp.Every change, in the filing's words
Appointed: Clay Ritchey, Chief Executive Officer, effective 2026-09-08
On August 28, 2026, the Board of Directors (the "Board") of Definitive Healthcare Corp. (the "Company") appointed Clay Ritchey as the Company's Chief Executive Officer and as a member of the Board, effective September 8, 2026.
Departing: Kevin Coop, Chief Executive Officer, effective 2026-08-31
Separation of Chief Executive Officer In connection with the appointment of Mr. Ritchey, on September 2, 2026, the Company announced that Kevin Coop has stepped down as the Company's Chief Executive Officer and as a member of the Board, effective August 31, 2026.
- Mr. Ritchey, age 55, most recently served as Advisor to the Board of Verato since June 2026, following his tenure as Chief Executive Officer of Verato, a leading master data management company, from April 2021 to May 2026.
- Prior to Verato, Mr. Ritchey held senior leadership positions at multiple healthcare-focused technology companies, including serving as Chief Executive Officer of Evariant from March 2017 to April 2020 (prior to its acquisition by Healthgrades), Chief Marketing Officer of Imprivata from October 2013 to March 2017, and Chief Executive Officer of Equinox Healthcare from April 2010 to April 2013 (where he led the sale of the company to AxelaCare Health Solutions).
- Earlier in his career, Mr. Ritchey held senior marketing and go-to-market positions with Hill-Rom and Kronos.
- Mr. Ritchey served on the boards of directors of Verato, Evariant and Equinox Healthcare from April 2021 to May 2026, March 2017 to April 2020, and April 2010 to April 2013, respectively.
- In connection with Mr. Ritchey's appointment, the Company entered into an employment agreement with Mr. Ritchey, dated August 28, 2026 (the "Employment Agreement").
- Pursuant to the Employment Agreement, Mr. Ritchey will receive an annual base salary of $500,000 and will be eligible to participate in the Company's annual bonus program with a target bonus of 87.5% of base salary.
Reported
Mr. Haywood's resignation was not the result of any disagreements with the Company relating to the Company's operations, policies or practices.
- On March 30, 2026, Jeff Haywood resigned from the Board of Directors (the "Board") of Definitive Healthcare Corp. (the "Company") and as a member of the Human Capital Management and Compensation Committee (the "Compensation Committee") of the Board, effective immediately.
- In connection with Mr. Haywood's resignation, the size of the Board was reduced from 9 members to 8 members, and the size of the Compensation Committee was reduced from 3 members to 2 members.
Tools for this story
Each opens in a new tab, filled in for Definitive Healthcare Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.